Genetics Generation Advancement Corp.
Research Genetics Generation Advancement Corp. (4160.TWO) on Bullrun: market cap TWD 1.09B, P/E 59.7. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4160.TWO
- ExchangeTWO
- CountryTaiwan
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyTWD
- Market capTWD 1.09B
- P/E59.7
- Financial periodQ2 2026
- RevenueTWD 150.38M
- Net incomeTWD 6.21M
- Free cash flow-TWD 16.18M
- Gross margin41.7%
Valuation Snapshot
latest market cap is TWD 1.09B; P/E is 59.7.
Peer valuation comparison
Latest P/E is 59.69x versus a Healthcare sector median of 21.8x (173.9% above).
Latest P/E is 59.69x versus a Taiwan median of 18.67x (219.8% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 1.09B | 59.7 | n/a | 1.76 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.76 TWD.
About Genetics Generation Advancement Corp.
Genetics Generation Advancement Corp. engages in the development and implementation of digital data management systems for gene testing, biological, chemical, and materials information in Taiwan. The company offers testing services, such as pre-implantation, prenatal stage, newborn medical examination, health management, reproductive medicine testing, obstetrics and gynecology, neonatology and pediatrics, oncology, and medical research services.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Genetics Generation Advancement Corp.'s market cap?
Genetics Generation Advancement Corp.'s market capitalization is TWD 1.09B.
What is Genetics Generation Advancement Corp.'s P/E ratio?
Genetics Generation Advancement Corp.'s price-to-earnings (P/E) ratio is 59.7.
What does Genetics Generation Advancement Corp. do?
Genetics Generation Advancement Corp. engages in the development and implementation of digital data management systems for gene testing, biological, chemical, and materials information in Taiwan. The company offers testing services, such as pre-implantation, prenatal stage, newborn medical examination, health management, reproductive medicine testing, obstetrics and gynecology, neonatology and pediatrics, oncology, and medical research services.